| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-07 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |